Search Results 691-700 of 15546 for Episodic

  1. Medical Research & Education - Mayo Clinic News Network

    Glenn Foundation for Medical Research Awards Mayo Clinic $3 Million to Study Biology of Aging. August 20, 2013. Minnesota.

  2. HT-3951 vs. Placebo in Stroke Rehabilitation - Mayo Clinic

    About this study. This is a randomized, double-blind, placebo-controlled parallel group outpatient study that will utilize standard stroke rehabilitation ...

  3. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy - Mayo Clinic

    A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With ...

  4. Effects of Aprepitant on Satiation, Gastric Volume, Gastric Accommodation and Gastric Emptying - Mayo Clinic

    This research study is being done to compare the effects of Aprepitant and placebo on fasting gastric volume, accommodation volume, satiation (fullness) and ...

  5. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  6. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researcher harnesses uniqueness of space to advance medicine on Earth. Cancer, stroke, bone loss among diseases and conditions studied in ...

  7. A Study of of IW-3718 in Patients with Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors - Mayo Clinic

    A Study of of IW-3718 in Patients with Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors · More about research at Mayo Clinic.

  8. Pediatrics Clinical Trials - Medical Professionals

    The purpose of this study is to derive and characterize patient-specific disease models for sudden death-predisposing heritable channelopathies and ...

  9. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...

  10. Tethered Capsule Endomicroscopy Surveillance of Barrett’s Esophagus Following Endoscopic Eradication Therapy - Mayo Clinic

    The purpose of this study is to explore the acceptability of tethered capsule endomicroscopy (TCE) for Barrett's Esophagus (BE) surveillance following CRIM. BE ...